Envoy Medical secures three new patents, bolstering cochlear implant leadership
The new patents cover critical advancements in cochlear implant technology
The new patents cover critical advancements in cochlear implant technology
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
Nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh
The pioneering monoclonal antibody is for Essential Thrombocythemia (ET) and Polycythemia Vera (PV), rare chronic blood cancers with limited treatment options
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
Subscribe To Our Newsletter & Stay Updated